Peripheral neuropathy — all decisions

The Board granted an initial rating of 30 percent for left ulnar neuropathy, but no greater.

The Board remands the claims for further development and readjudication.

The Board remands the Veteran's claims for service connection for peripheral neuropathy and restless leg syndrome of both lower extremities to provide notice concerning his right to a pre-decisional hearing before the AOJ.

The Board remands the claims for service connection for diabetes mellitus type II, a brain tumor, erectile dysfunction, and diabetic sensory peripheral neuropathy to further develop evidence of herbicide exposure.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Veteran's service-connected peripheral neuropathy (PN) of the lower extremities, alone, prevents him from securing and following substantially gainful employment.

The Board granted an effective date of March 2, 2023 for heart disease and September 28, 2023 for chronic renal failure, while denying earlier effective dates for PTSD, migraines, diabetes mellitus type II, hypertension, and bilateral hearing loss. The Board also granted a 70 percent evaluation for PTSD.

The Board granted service connection for left and right lower extremity peripheral neuropathy, other than under the PACT Act, as well as coronary artery disease, on a presumptive basis due to herbicide exposure.

The Board granted service connection for diabetes mellitus, type II, with neuropathy of the right upper extremity on an accrued basis due to presumed inservice herbicide exposure.

The Board granted service connection for various conditions, including neck disability manifested by pain and diabetes mellitus type II, secondary to the Veteran's service-connected bilateral knee degenerative arthritis. The other conditions were also granted as they are caused by the now-service-connected diabetes mellitus type II.

The Board denied the Veteran's claim for financial assistance in the purchase of an automobile or other conveyance, or adaptive equipment due to a lack of evidence supporting permanent loss of use of his hands and feet.

The Board granted initial 40 percent ratings for peripheral neuropathy of the left and right lower extremities, as well as separate service connection for moderate incomplete paralysis of the superficial peroneal nerve in both legs, and a total disability rating based on individual unemployability (TDIU) prior to January 28, 2020.

The appeal for service connection for multiple conditions was dismissed due to the untimely filing of the Board Appeal request.

The Board granted service connection for multiple disabilities, including various musculoskeletal conditions and mental health disorders.

The Board granted service connection for idiopathic peripheral polyneuropathy in both the right and left lower extremities, finding a causal relationship to Agent Orange exposure.

The Board granted service connection for tinnitus and denied service connection for hypertension, heart disease, kidney condition, diabetes, left lower extremity neuropathy, left upper extremity neuropathy, right lower extremity neuropathy, right upper extremity neuropathy, depression, and bilateral hearing loss.